Johnson SB. Psychological impact of screening and prediction in type 1 diabetes. Curr Diab Rep. 2011;11(5):454–9. https://doi.org/10.1007/s11892-011-0208-9.
Tosur M, Onengut-Gumuscu S, Redondo MJ. Type 1 diabetes genetic risk scores: history, application and future directions. Curr Diab Rep. 2025;25:22. https://doi.org/10.1007/s11892-025-01575-5.
Haller MJ, Bell KJ, Besser REJ, Casteels K, Couper JJ, Craig ME, et al. ISPAD clinical practice consensus guidelines 2024: Screening, staging, and strategies to preserve beta-cell function in children and adolescents with type 1 diabetes. Horm Res Paediatr. 2024;97:529–45. https://doi.org/10.1159/000543035.
Article CAS PubMed Google Scholar
Phillip M, Achenbach P, Addala A, Albanese-O’Neill A, Battelino T, Bell KJ, et al. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care. 2024;47(8):1276–98. https://doi.org/10.1007/s00125-024-06205-5.
Article CAS PubMed PubMed Central Google Scholar
Insel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, et al. Staging for presymptomatic type 1 diabetes: a scientific statement of JDRF, the endocrine Society, and the American diabetes association. Diabetes Care. 2015;38(10):1964–74. https://doi.org/10.2337/dc15-1419.
Article CAS PubMed PubMed Central Google Scholar
Evans-Molina C, Oram RA. Teplizumab approval for type 1 diabetes in the USA. Lancet Diabetes Endocrinol. 2023;11(2):76–7. https://doi.org/10.1016/S2213-8587(22)00391-6.
Article CAS PubMed Google Scholar
O’Donnell HK, Rasmussen CG, Dong F, Simmons KM, Steck AK, Frohnert B, et al. Anxiety and risk perception in parents of children identified by populations screening as high risk for type 1 diabetes. Diabetes Care. 2023;46(12):2155–61. https://doi.org/10.2337/dc23-0350.
Ziegler A, Kick K, Bonifacio E, Haupt F, Hippich M, Dunstheimer D, et al. Yield of a public health screening of children for islet autoantibodies in Bavaria. Ger JAMA. 2020;323(4):339–51. https://doi.org/10.1001/jama.2019.21565.
Bell KJ, Brodie S, Couper JJ, Colman P, Davis E, Deedet G, et al. Protocol for the Australian type 1 diabetes national screening pilot: assessing the feasibility and acceptability of three general population screening models in children. Diabet Med. 2024;41(11):e15419. https://doi.org/10.1111/dme.15419.
Quinn LM, Shukla D, Greenfield SM, Barrett T, Garstang J, Boardman F, et al. Early surveillance for autoimmune diabetes: protocol for a qualitative study of general population and stakeholder perspectives on screening for type 1 diabetes in the UK (ELSA 1). BMJ Open Diabetes Res Care. 2022;10(2):e002750. https://doi.org/10.1136/bmjdrc-2021-002750.
Article PubMed PubMed Central Google Scholar
Oron T, Cortez FJ, Shtaif B, Robinson PV, Yackobovitch-Gavan M, Tandel D, et al. Detection of islet autoantibodies in whole blood by antibody detection by agglutination-PCR (ADAP) technology is sensitive and suitable for general population screening programs. Pediatr Diabetes. 2024. https://doi.org/10.1155/2024/4238394. Article ID 4238394.
Article PubMed PubMed Central Google Scholar
American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes-2025. Diabetes Care 2025;48(Suppl1):S27-S49. https://doi.org/10.2337/dc25-S002
Jacobson LM, Atkinson MA, Sosenko JM. Time to reframe the disease staging system for type 2 diabetes. Lancet Diabetes Endocrinol. 2024;12:924–33. https://doi.org/10.1016/S2213-8587(24)00239-0.
Tluczek A, Ersig A, Lee S. Psychosocial issues related to newborn screening: a systematic review and synthesis. Int J Neonatal Screen. 2022;8(4):53. https://doi.org/10.3390/ijns8040053.
Article PubMed PubMed Central Google Scholar
Khan RK, Misra R, Shawley-Brzoska S, Wen S. Predictors of diabetes risk perception among college students. J Am Coll Health. 2022;70(6):1803–9. https://doi.org/10.1080/07448481.2020.1825222.
Daack-Hirsch S, Shah LL, Jones K, Rocha B, Doerr M, Gabitzsch E, et al. All things considered, my risk for diabetes is medium: A risk personalization process of familial risk for type 2 diabetes. Health Expect. 2020;23:169–81. https://doi.org/10.1111/hex.12986.
Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A, Walker EA. Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care. 2007;30(9):2281–6. https://doi.org/10.2337/dc07-0618.
de la Haye K, Whitted C, Koehly L. Formative evaluation of the families SHARE disease risk tool among low-income African Americans. Pub Health Genomics. 2021;24:280–90. https://doi.org/10.1159/000517309.
Swartling U, Lynch K, Smith L, Johnson SB. Parental estimation of their child’s increased type 1 diabetes risk during the first 2 years of participation in an international observational study: results from the TEDDY study. J Empir Res Hum Res Ethics. 2016;11(2):106–14. https://doi.org/10.1177/1556264616648589.
Article PubMed PubMed Central Google Scholar
Kerruish NJ, Healey DM, Gray AR. Psychosocial effects in parents and children 12 years after newborn genetic screening for type 1 diabetes. Eur J Hum Genet. 2017;25:397–403. https://doi.org/10.1038/ejhg.2016.190.
Article PubMed PubMed Central Google Scholar
O’Donnell HK, Tamura R, Smith L, Driscoll K, Melin J, Simmons K, Johnson SB, the TEDDY Study Group. Child Understanding of risk for type 1 diabetes: the TEDDY study. Clin Diabetes April. 2025. https://doi.org/10.2337/cd24-0080.
Kerruish NJ. Parents’ experiences of newborn screening for genetic susceptibility to type 1 diabetes. J Med Ethics. 2011;37:348–53. https://doi.org/10.1136/jme.2010.039206.
Whittmore R, Jaser S, Chao A, Jang M, Grey M. Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ. 2012;38(4):562–79. https://doi.org/10.1177/0145721712445216.
Houben J, Janssens M, Winkler C, Besser REJ, Dzygalo K, Fehn A, et al. The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study. Pediatr Diabetes. 2022;23:1707–16. 10.111/pedi.13448.
Wade CH, Wilfond BS, McBride DM. Effects of genetic risk information on children’s psychosocial well-being: a systematic review of the literature. Genet Med. 2010;12(6):317–26. https://doi.org/10.1097/GIM.0b013e3181de695c.
Wells GA, Russell AS, Haraoui B, Bissonnette R, Ware C. Validity of quality of life measurement tools-from generic to disease-specific. J Rheum. 2011;88(Suppl):2–6. https://doi.org/10.3899/jrheum.110906.
Hood KK, Johnson SB, Baughcum AE, She JX, Schatz D. Maternal understanding of infant diabetes risk: differential effects of maternal anxiety and depression. Genet Med. 2006;8(10):665–70. https://doi.org/10.1097/gim.0000237794.24543.4d.
Driscoll KA, Melin J, Lynch KF, Smith LB, Johnson SB. SAI-CH-6: development of a short form of the state anxiety inventory for children at-risk for type 1 diabetes. J Pediatr Psychol. 2023;48:861–9. https://doi.org/10.1093/jpepsy/ksad057.
Article PubMed PubMed Central Google Scholar
Johnson SB, Lynch KF, Roth R, Schatz D, the TEDDY Study Group. My child is islet autoantibody positive: impact on parental anxiety. Diabetes Care. 2017;40(9):1167–72. https://doi.org/10.2337/dc17-0166.
Article PubMed PubMed Central Google Scholar
Roth R, Lynch K, Lernmark B, Baxter J, Simell T, Smith L, et al. Maternal anxiety about a child’s diabetes risk in the TEDDY study: the potential role of life stress, postpartum depression, and risk perception. Pediatr Diabetes. 2015;16(4):287–98. https://doi.org/10.1111/pedi.12168.
Smith LB, Liu X, Johnson SB, et al. Family adjustment to diabetes diagnosis in children: can participation in a study on type 1 diabetes genetic risk be helpful? Pediatr Diabetes. 2018;19(5):1025–33. https://doi.org/10.1111/pedi.12674.
Comments (0)